Diagnosing Tuberculosis Pamela Hepple Medecins Sans Frontieres UK.

Slides:



Advertisements
Similar presentations
TB 101 “Basic Facts on Tuberculosis”
Advertisements

TB Diagnostics Chest X-Ray Hello
ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
Agenda Background Current testings Xpert MTB/RIF product PAGE | 1.
` COMPARATIVE ACCURACY OF CARTRIDGE BASED NUCLEIC ACID AMPLIFICATION TEST AND SPUTUM MICROSCOPY FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN HIV POSITIVE.
New approaches in TB diagnosis and treatment Prof. M.A. Tageldin.
June 2004 HITCH Training Slide Set #3 Special Considerations in Antiretroviral Therapy.
Improving diagnosis TB laboratory strengthening.
Country Update: Tuberculosis in Thailand
1 |1 | Implementing HIV and TB Diagnostics in Resource Cape Town, South Africa, September 23 rd, 2014 New diagnostic technologies in development and target.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Nucleic Acid Amplification Test for Tuberculosis
1 Identifying Cases of MDR-TB Session 3. USAID TB CARE II PROJECT Old WHO recommendations RegimenIndications 4HREZ/2HR (Category I) New cases 2SHREZ/1HREZ/5HRE.
Development of extensive drug resistance in Multi-Drug resistant tuberculosis patients MSF anti-TB programmes in Abkhazia and Uzbekistan Authors: Cathy.
International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Diagnosis of TB.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Molecular methods for TB drug resistance testing: what is needed? Experience from Khayelitsha, Cape Town, South Africa Helen Cox, PhD, Burnet Institute.
Module 1: Overview of tuberculosis (TB) and TB diagnostics Global Laboratory Initiative – Xpert MTB/RIF Training Package.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
Multi-drug resistant tuberculosis: Progress and challenges in South Africa Dr S. Moyo HIV/AIDS, Sexually Transmitted Infections and TB research (HAST)Programme.
British Society for Microbial Technology The laboratory diagnosis of tuberculosis 25 years of progress D A Mitchison St George’s, University of London.
DEPARTMENT OF HEALTH DOTS Program for TB (Tuberculosis Directly Observed Short-course)
Tuberculosis Research of INA-RESPOND on Drug-resistant
Introduction to the course 1. Agenda Include: TECHNICAL ISSUES PRACTICAL ISSUES 2.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Implementation of Thin Layer Agar for Mycobacterium culture in rural Kenya Médecins Sans Frontières.
2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 Figure 1. Number of Tuberculosis Cases: California,
1 |1 | Dr Karin Weyer Stop TB Department Geneva, Switzerland Strategic guidance on the use of laboratory technologies DEWG Meeting, Geneva: 13 October.
Revising the WHO TB Treatment Guidelines Process and new recommendations Malgosia Grzemska Matteo Zignol Stop TB Department World Health Organization DEWG.
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 7: GAP BETWEEN AVAILABILTY OF DRUG SUSCEPTIBILITY.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 8.
TB Control Measures: From development and endorsement to adoption and implementation Léopold Blanc TBS Stop TB department WHO Christy Garcia University.
Number of Tuberculosis Cases: California, Number of Tuberculosis Cases.
Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Patient with Presumptive TB HIV Status PositiveNegative % Empiric Tx of Patients with Active TB % Empiric Tx of TB-Symptomatic Patients without True TB.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
Figure 1. Number of Tuberculosis Cases: California, Number of Tuberculosis Cases
EBM Appraisal (Diagnostics). Clinical Scenario You are the duty resident at the traige on a Sunday afternoon when... a 3 year old Male came with a chief.
LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.
Roundtable. Detection and treatment of TB Andrew Black.
Case Discussion 2 - TB IN CHILDREN by Dr. Jeyaseelan P. Nachiappan & Dr. Suryati Adnan 1 Picture of CPG Cover.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
The story of Munya* (and us)
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
World Tuberculosis Day 2014
Summary of changes in the RNTCP technical guidelines in
This is an archived document.
World Tuberculosis Day 2013
World Tuberculosis Day 2014
Dr Dawood Quiz questions.
Nucleic Acid Amplification Test for Tuberculosis
Laboratory ‘Network’ Update New York State Department of Health
Tuberculosis situation in the EU/EEA, 2016
World Tuberculosis Day 2014
World Tuberculosis Day 2016
World Tuberculosis Day 2014
Module 9 Recording and reporting culture results
Tb: Screening & Diagnosis (1)
Indian Scenario HIV Situation TB Situation
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
Success and failure in TB surveillance in Hungary
Timeline of development of key elements of the Cambodian MDR-TB treatment programme. *GLC1 application for patients enrolled in the CAMbodian Early vs.
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Presentation transcript:

Diagnosing Tuberculosis Pamela Hepple Medecins Sans Frontieres UK

Diagnosis of pulmonary TB is done very differently according to context

In developed countries Symptom/resultTestTimeframe 1Cough/bloody phlegmX-ray/ CT scan1 day 2Cough/bloody phlegmSmear microscopy (concentrated) 2-3 days 3Cough/bloody phlegmSputum culture (liquid + solid media) 2-4 weeks 4Positive cultureDrug-sensitivity testing (1 st line) 1-2 weeks 5Multi-drug resistantDST (2 nd line)1-2 weeks

A typical patient can receive a diagnosis of MDR TB within 3 weeks, and a tailored drug regimen within 4 weeks. High-risk suspects can have molecular- based tests for diagnosis and drug-resistance which can give results within one day.

In most high-burden countries Symptom/resultTest/procedureTimeframe 1Cough/bloody phlegmSmear microscopy2-3 days (if TB programme is functional) 2Smear-positiveCategory I treatment6 – 8 months 3Smear-positive at 6 months Category II treatment6 – 8 months 4Smear-positive at end Category 2 treatment Culture and DST on solid media* 2 – 3 months

It can take up to 18 months for a patient to be diagnosed with MDR TB The vast majority of TB patients do not have access to culture or molecular diagnostic techniques, so will never be diagnosed with and treated for MDR TB Most patients rely on smear microscopy for TB diagnosis – 60% sensitivity at best Culture is gold standard – has 100% sensitivity